Cian Healthcare Ltd.
Snapshot View

24.00 -1.25 ▼-5.0%

27 January 2023, 04:01:00 PM
Volume: 24,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cian.co
Market Cap 60.36 Cr.
Enterprise Value(EV) 121.60 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -2.21 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 32.90 Trailing Twelve Months Ending 2022-03
Book Value / Share 21.03 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.14 Calculated using Price: 24.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.50 Cr. 24,995,764 Shares
FaceValue 10
Company Profile
The Company develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, along with 10 sales division focused on developing and growing its engagements in specialist and super specialist division. The company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies. The Company manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.95%
1 Week
+14.83%
1 Month
+29.73%
3 Month
+51.90%
6 Month
+60.0%
1 Year
-21.05%
2 Year
+95.92%
5 Year
10 Year
3 years 2020-03 2021-03 2022-03
Return on Equity (%) -7.53 0.10 -10.51
Return on Capital Employed (%) 3.00 6.99 0.46
Return on Assets (%) -2.42 0.03 -3.42

Balance Sheet View Details >>

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 58 58 55
Non Curr. Liab. 50 41 41
Curr. Liab. 48 58 69
Minority Int.
Equity & Liab. 157 157 166
Non Curr. Assets 94 88 84
Curr. Assets 54 63 79
Misc. Exp. not W/O 8 5 3
Total Assets 157 157 166

Profit Loss View Details >>

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 57 74 78
Other Income 1 0 1
Total Income 58 74 78
Total Expenditure -50 -62 -74
PBIDT 8 12 5
Interest -7 -8 -7
Depreciation -4 -3 -4
Taxation 0 -1 0
Exceptional Items 0 0 0
PAT -4 0 -6
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -4 0 -6
Adjusted EPS -2 0 -2

Cash Flow View Details >>

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -7 6 9
Cash Fr. Inv. -27 3 1
Cash Fr. Finan. 36 -10 -11
Net Change 1 -1 -1
Cash & Cash Eqvt 3 2 1

Shareholding Pattern View Details >>

9 Qtrs 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-09 (%) 2022-12 (%)
Promoter 70.89 70.89 70.89 70.89 70.89 66.26 66.26 66.26 66.26
Public 29.11 29.11 29.11 29.11 29.11 33.74 33.74 33.74 33.74
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 10.14 10.14 10.14 10.14 20.14 14.11 34.11 34.11 34.11

Announcements View Details >>

Mon, 16 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74 (5) OF SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31st December 2022.
Fri, 23 Dec 2022
REVISED SUBMISSION OF HALF YEARLY UNAUDITED FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30TH SEPTEMBER 2022 AS PER REGULATION 33 OF SEBI (LODR) REGULATIONS 2015.
REVISED SUBMISSION OF HALF YEARLY UNAUDITED FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30TH SEPTEMBER 2022 AS PER REGULATION 33 OF SEBI (LODR) REGULATIONS 2015.
Mon, 14 Nov 2022
SUBMISSION OF HALF YEARLY UNAUDITED FINANCIAL RESULTS OF CIAN HEALTHCARE LIMITED FOR THE HALF YEAR ENDED 30TH SEPTEMBER 2022 AS PER REGULATION 33 OF SEBI (LODR) REGULATIONS 2015.
In pursuance of the SEBI (Listing Obligations & Disclosure Requirement) Regulations 2015 (Listing Regulations) please be informed that the Board of Directors at its meeting held on today i.e. Monday November 14 2022 to inter alia considered and approved the Un-Audited Financial Results (standalone and consolidated) for the quarter and half year ended September 30 2022 and took on record the Limited Review Report issued by the Statutory Auditors of the Company.

Technical Scans View Details >>

Fri, 27 Jan 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Above Last Week High Close Above Last Week High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Cian Healthcare Ltd.

What is Cian Healthcare share price?

Can I buy Cian Healthcare shares now?

What is the Market Cap of Cian Healthcare?

What are the key metrics to analyse Cian Healthcare?

What is the 52 Week High and Low of Cian Healthcare?

What is the trend of Cian Healthcare share price?